Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC). - Boschi C; Colson P; Bancod A; Moal V; La Scola B (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022)